Nine types of drugs commonly administered to horses include analgesics (flunixin meglumine), anthelmintics (fenbendazole, ivermectin, moxidectin, oxfendazole, oxibendazole, praziquantel, pyrantel pamoate, pyrantel tartrate), antibiotics (gentamicin, penicillin, tetracycline, trimethoprim sulfa), antipyretics (ketoprofen, phenylbutazone), bronchodilators (albuterol, clenbuterol), corticosteroids (dexamethasone, prednisone), NSAIDs (flunixin meglumine, naproxen, phenylbutazone), sedatives (detomidine, xylazine), and tranquilizers (acetylpromazine, promazine). Equine joint supplements have been purported to decrease inflammation, increase mobility, provide the building blocks for articular cartilage synthesis, and/or contribute to the overall health of movable joints by some other mechanism. These supplements often are used for young, athletic horses to try to protect the healthy horse from injury, for treatment for a joint injury, and in older horses to try to counteract a lifetime of joint wear-and-tear. Veterinary nutritional supplements or nutraceuticals contain one or more dietary ingredients intended to supplement the diet. Such ingredients include vitamins, minerals, herbs or other botanical products, amino acids (the building blocks for proteins), and substances such as enzymes, organ tissues, glandulars, metabolites, extracts, or concentrates. Nutritional supplements for horses are available in a number of formulations, including pellets, granules, powders, pastes, liquids, injections (intravenous or intramuscular), and pills.
The global equine drugs and supplements market segmentation is based on pharmaceutical drugs (anti-anxiety and sedative drugs, nonsteroidal anti-inflammatory drugs, tranquilizers, others), supplements (gastric and ulcer supplements, joint supplements, minerals and vitamins, other supplements), and distribution channel (drugstores, veterinary hospitals, others).
The major equine drugs and supplements by brand include anti-anxiety and sedative drugs – clomipramine (clomicalm), detomidine (dormosedan), diazepam (valium), fentanyl, fluoxetine (prozac), pethidine, romifidine (sedivet), xylazine (rompun); nonsteroidal anti-inflammatory drugs (NSAIDs) – firocoxib (equioxx), flunixin , flunixin meglumine (banamine), ketoprofen (ketofen), phenybutazone (bute); tranquilizers – acepromazine, fluphenazine, promace, reserpine, valium, xanax (alprazolam); by supplement type into gastric and ulcer supplements – gastro guard, ulcer guard; joint supplements – adequan, legend, pentosane; minerals and vitamins; other supplements and other drugs and supplements.
The global equine drugs and supplements market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global equine drugs and supplements market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global equine drugs and supplements market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.
Major players operating in the equine drugs and supplements market and included in this report are Bayer Animal Health, Boehringer Ingelheim, Elanco (Eli Lilly), Merck Animal Health, Merial, Novartis Animal Health, and Zoetis.